Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Narikazu Boku
Observed name:
N. Boku
Institutions:
University of Tokyo Hospital,
IMSUT Hospital,
Institute of Medical Science, The University of Tokyo,
The University of Tokyo
Observed institutions:
National Cancer Centre Japan,
University of Tokyo Hospital,
National Cancer Center Hospital East,
IMSUT Hospital,
National Cancer Center Hospital,
Institute of Medical Science, The University of Tokyo,
The University of Tokyo
show all 7
ORCID:
0000-0003-1330-9229
Observed ORCID:
0000-0003-1330-9229
OpenAlex ID:
A5102769016
Development and Validation of an Esophageal Squamous Cell Carcinoma Detection Model by Large-Scale MicroRNA Profiling
2019
·
Kazuki Sudo
, Ken Kato
, et al.
·
JAMA Network Open
·
85
PDF
Monitoring of cancer patients via next‐generation sequencing of patient‐derived circulating tumor cells and tumor DNA
2019
·
Kaoru Onidani
, Hirokazu Shoji
, et al.
·
Cancer Science
·
75
PDF
Prediction of tissue-of-origin of early stage cancers using serum miRNomes
2022
·
Juntaro Matsuzaki
, Ken Kato
, et al.
·
JNCI Cancer Spectrum
·
42
PDF
Identification of serum microRNAs predicting the response of esophageal squamous-cell carcinoma to nivolumab
2019
·
Kazuki Sudo
, Ken Kato
, et al.
·
Japanese Journal of Clinical Oncology
·
31
Patterns of Relapse after Definitive Chemoradiotherapy in Stage II/III (Non-T4) Esophageal Squamous Cell Carcinoma
2017
·
Kazuki Sudo
, Ken Kato
, et al.
·
Oncology
·
18
Indications for fertility preservation not included in the 2017 Japan Society of Clinical Oncology Guideline for Fertility Preservation in Pediatric, Adolescent, and Young Adult Patients treated with gonadal toxicity, including benign diseases
2021
·
Masanori Ono
, Kimikazu Matsumoto
, et al.
·
International Journal of Clinical Oncology
·
12
PDF
Study protocol for NCCH1908 (UPFRONT-trial): a prospective clinical trial to evaluate the feasibility and utility of comprehensive genomic profiling prior to the initial systemic treatment in advanced solid tumour patients
2021
·
Takaaki Mizuno
, Tatsuya Yoshida
, et al.
·
Japanese Journal of Clinical Oncology
·
12
PDF
Phase II trial of nab-paclitaxel plus ramucirumab in combination with nivolumab for unresectable advanced or recurrent gastric cancer after progression on first-line treatment including fluoropyrimidine, platinum, and anti-PD-1/PD-L1 antibody (PADDLE)
2025
·
Hidekazu Hirano
, Naoki Takahashi
, et al.
·
BMC Cancer
·
7
PDF
Clinical benefits of adding olanzapine to 5-HT3 receptor antagonist, NK1 receptor antagonist, and dexamethasone for the prevention of nausea and vomiting in highly emetogenic chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023 from the Japan Society of Clinical Oncology
2024
·
Michiyasu Murakami
, Yoshiharu Miyata
, et al.
·
International Journal of Clinical Oncology
·
7
Long-term outcomes after non-curative endoscopic resection for esophageal squamous cell carcinoma followed by additional chemoradiotherapy
2024
·
Hourin Cho
, Seiichiro Abe
, et al.
·
Diseases of the Esophagus
·
6
Geriatric assessment and management with question prompt list using a web-based application for elderly patients with cancer to communicate aging-related concerns: A randomized clinical trial (J-SUPPORT 2101 study).
2024
·
Ayumu Matsuoka
, Maiko Fujimori
, et al.
·
Journal of Clinical Oncology
·
3
PDF
Development and validation of a prognostic nomogram for survival in patients with brain metastases from colorectal cancer
2025
·
Jun Imaizumi
, Dai Shida
, et al.
·
Scientific Reports
·
2
PDF
Correction to: Long‑term outcomes of patients with recurrent squamous cell carcinoma of the esophagus undergoing salvage endoscopic resection after definitive chemoradiotherapy
2020
·
Mai Ego
, Seiichiro Abe
, et al.
·
Surgical Endoscopy
·
2
PDF
Geriatric assessment and management with a question prompt list using a web-based application to reduce treatment toxicity in older patients with cancer: A randomized controlled trial (J-SUPPORT 2101 study).
2025
·
Ayumu Matsuoka
, Maiko Fujimori
, et al.
·
Journal of Clinical Oncology
·
1
PDF
Efficacy and safety of dexamethasone sparing for the prevention of nausea and vomiting associated with moderately emetogenic chemotherapy: a systematic review and meta-analysis of Clinical Practice Guidelines for Antiemesis 2023 from Japan Society of Clinical Oncology
2024
·
Kazuhisa Nakashima
, Ayako Yokomizo
, et al.
·
International Journal of Clinical Oncology
·
1
Serum microRNAs to predict the response to nivolumab in patients with esophageal squamous cell carcinoma.
2017
·
Kazuki Sudo
, Ken Kato
, et al.
·
Journal of Clinical Oncology
·
1
Efficacy and safety of multi-day antiemetic treatment for patients undergoing multi-day chemotherapy: a systematic review of Clinical Practice Guidelines for Antiemesis 2023 from Japan Society of Clinical Oncology
2024
·
Kazuhisa Nakashima
, Saki Harashima
, et al.
·
International Journal of Clinical Oncology
PDF
12. Recent Progress of Systemic Chemotherapy for Gastrointestinal Cancer
2024
·
Narikazu Boku
·
Nihon Naika Gakkai Zasshi
PDF
Correction to: Indications for fertility preservation not included in the 2017 Japan Society of Clinical Oncology Guideline for Fertility Preservation in Pediatric, Adolescent, and Young Adult Patients treated with gonadal toxicity, including benign diseases
2022
·
Masanori Ono
, Kimikazu Matsumoto
, et al.
·
International Journal of Clinical Oncology
PDF
Cddp耐性食道癌患者に対するfolfoxによる根治的化学放射線療法の後ろ向き分析【jst・京大機械翻訳】|||
2021
·
Yada Mayu
, Yamamoto Shun
, et al.
·
日本臨床腫瘍学会学術集会(CD-ROM)
Detection of esophageal cancer patients using circulating serum microRNA from the result of comprehensive analysis
2017
·
K. Kato
, K. Sudo
, et al.
·
Annals of Oncology
PDF
腹膜転移を有する進行胃がんに対する5‐FU持続静注療法(5‐FU ci)vs MTX+5‐FU時間差療法(MF)第III相試験(JCOG0106試験)
2010
·
Kensei Yamaguchi
, Kuniaki Shirao
, et al.
·
日本臨床腫瘍学会学術集会プログラム・抄録集
Show more works
View as search
Works count:
22
Citation count:
305
H-index:
7
I10-index:
7
Year
Topic
Type